128 related articles for article (PubMed ID: 21623385)
1. Cytoplasmic p63 immunohistochemistry is a useful marker for muscle differentiation: an immunohistochemical and immunoelectron microscopic study.
Martin SE; Temm CJ; Goheen MP; Ulbright TM; Hattab EM
Mod Pathol; 2011 Oct; 24(10):1320-6. PubMed ID: 21623385
[TBL] [Abstract][Full Text] [Related]
2. Potential utility of CD5 immunohistochemical staining in the diagnosis of muscle tumors.
McNab PM; DeMers NM; Schlauder S; Morgan M; Nasir A; Coppola D; Bui MM
Ann Clin Lab Sci; 2009; 39(2):108-13. PubMed ID: 19429795
[TBL] [Abstract][Full Text] [Related]
3. A panel of antibodies to determine site of origin and malignancy in smooth muscle tumors.
Lee CH; Turbin DA; Sung YC; Espinosa I; Montgomery K; van de Rijn M; Gilks CB
Mod Pathol; 2009 Dec; 22(12):1519-31. PubMed ID: 19734847
[TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.
Allen MM; Douds JJ; Liang SX; Desouki MM; Parkash V; Fadare O
Int J Clin Exp Pathol; 2015; 8(3):2795-801. PubMed ID: 26045786
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of beta 1 integrins in nonneoplastic smooth and striated muscle cells and in tumors derived from these cells.
Mechtersheimer G; Barth T; Quentmeier A; Möller P
Am J Pathol; 1994 Jun; 144(6):1172-82. PubMed ID: 7515557
[TBL] [Abstract][Full Text] [Related]
6. Smoothelin is a specific marker for smooth muscle neoplasms of the gastrointestinal tract.
Coco DP; Hirsch MS; Hornick JL
Am J Surg Pathol; 2009 Dec; 33(12):1795-801. PubMed ID: 19950405
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.
Werling RW; Hwang H; Yaziji H; Gown AM
Am J Surg Pathol; 2003 Jan; 27(1):82-90. PubMed ID: 12502930
[TBL] [Abstract][Full Text] [Related]
8. p63 expression is associated with high histological grade, aberrant p53 expression and TP53 mutation in HER2-positive breast carcinoma.
Guo S; Wang Y; Rohr J; Shang L; Ma J
J Clin Pathol; 2021 Oct; 74(10):641-645. PubMed ID: 32873702
[TBL] [Abstract][Full Text] [Related]
9. Occasional staining for p63 in malignant vascular tumors: a potential diagnostic pitfall.
Kallen ME; Nunes Rosado FG; Gonzalez AL; Sanders ME; Cates JM
Pathol Oncol Res; 2012 Jan; 18(1):97-100. PubMed ID: 21667345
[TBL] [Abstract][Full Text] [Related]
10. p63 expression in benign and malignant breast lesions.
Stefanou D; Batistatou A; Nonni A; Arkoumani E; Agnantis NJ
Histol Histopathol; 2004 Apr; 19(2):465-71. PubMed ID: 15024707
[TBL] [Abstract][Full Text] [Related]
11. [Medullomyoblastoma: a medulloblastoma with rhabdomyoblastic differentiation].
Gauchotte G; Baylac F; Marie B; Vignaud JM
Ann Pathol; 2010 Apr; 30(2):135-8. PubMed ID: 20451073
[TBL] [Abstract][Full Text] [Related]
12. The cardiac isoform of alpha-actin in regenerating and atrophic skeletal muscle, myopathies and rhabdomyomatous tumors: an immunohistochemical study using monoclonal antibodies.
Moll R; Holzhausen HJ; Mennel HD; Kuhn C; Baumann R; Taege C; Franke WW
Virchows Arch; 2006 Aug; 449(2):175-91. PubMed ID: 16715231
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of p63/P501S double sequential immunohistochemical staining in differentiating urothelial carcinoma from prostate carcinoma.
Srinivasan M; Parwani AV
Diagn Pathol; 2011 Jul; 6():67. PubMed ID: 21777423
[TBL] [Abstract][Full Text] [Related]
14. p40 is a more specific marker than p63 for cutaneous poorly differentiated squamous cell carcinoma.
Alomari AK; Glusac EJ; McNiff JM
J Cutan Pathol; 2014 Nov; 41(11):839-45. PubMed ID: 25263848
[TBL] [Abstract][Full Text] [Related]
15. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.
Cessna MH; Zhou H; Perkins SL; Tripp SR; Layfield L; Daines C; Coffin CM
Am J Surg Pathol; 2001 Sep; 25(9):1150-7. PubMed ID: 11688574
[TBL] [Abstract][Full Text] [Related]
16. PAX2 expression in Wilms tumors and other childhood neoplasms.
Davis JL; Matsumura L; Weeks DA; Troxell ML
Am J Surg Pathol; 2011 Aug; 35(8):1186-94. PubMed ID: 21730820
[TBL] [Abstract][Full Text] [Related]
17. An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies.
Oliva E; Young RH; Amin MB; Clement PB
Am J Surg Pathol; 2002 Apr; 26(4):403-12. PubMed ID: 11914617
[TBL] [Abstract][Full Text] [Related]
18. Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray.
Reis-Filho JS; Simpson PT; Martins A; Preto A; Gärtner F; Schmitt FC
Virchows Arch; 2003 Aug; 443(2):122-32. PubMed ID: 12884041
[TBL] [Abstract][Full Text] [Related]
19. p40 (ΔNp63) expression in breast disease and its correlation with p63 immunohistochemistry.
Kim SK; Jung WH; Koo JS
Int J Clin Exp Pathol; 2014; 7(3):1032-41. PubMed ID: 24696720
[TBL] [Abstract][Full Text] [Related]
20. p53 family members in myogenic differentiation and rhabdomyosarcoma development.
Cam H; Griesmann H; Beitzinger M; Hofmann L; Beinoraviciute-Kellner R; Sauer M; Hüttinger-Kirchhof N; Oswald C; Friedl P; Gattenlöhner S; Burek C; Rosenwald A; Stiewe T
Cancer Cell; 2006 Oct; 10(4):281-93. PubMed ID: 17045206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
